Biotech

All Articles

Analysts examine Avidity's DMD succeed, exposing subtleties in information

.Avidity Biosciences impressed capitalists along with period 1/2 data in Duchenne muscular dystrophy...

Actinogen's cortisol blocker neglects phase 2 clinical depression research

.Actinogen Medical's cortisol blocker has actually missed the primary endpoint of a period 2 researc...

Bivictrix makes a decision going personal only means to take ADC in to facility

.Antibody-drug conjugates (ADCs) have actually gone to the center of lots of a billion-dollar biobuc...

TPG tops up funds to $580M for expenditures all over lifestyle sciences

.Possession manager TPG, which has assisted biotechs like Sionna Therapies as well as Santa Ana Biog...

Merck ceases stage 3 TIGIT test in lung cancer cells for futility

.Merck &amp Co.'s TIGIT program has suffered another misfortune. Months after shuttering a stage 3 c...

After a tough year, Exscientia folds in to Recursion

.After a year described through pipeline hairstyles, the variation of its own chief executive office...

Cullinan, after $25M offer, hands back bispecific to Port

.Cullinan Rehab was actually wowed sufficient with Port BioMed's bispecific immune reactor that it e...

A nearer look at Intense Biotech's Strong 15

.Within this week's incident of "The Top Pipe," our experts are actually diving in to Brutal Biotech...

Lilly experiences stage 2 failure of tau-targeting med

.The confetti is still soaring from Eli Lilly's event celebrating the commendation of Alzheimer's di...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our roundup of significant leadership hirings, shootings...